Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marie-Laure, Bonnefond"'
Autor:
Marie-Laure, Bonnefond, Romane, Florent, Sophie, Lenoir, Bernard, Lambert, Edwige, Abeilard, Florence, Giffard, Marie-Hélène, Louis, Nicolas, Elie, Mélanie, Briand, Denis, Vivien, Laurent, Poulain, Pascal, Gauduchon, Monique, N'Diaye
Publikováno v:
Oncotarget
The anti-apoptotic proteins Bcl-xL and Mcl-1 have been identified to play a pivotal role in apoptosis resistance in ovarian cancer and constitute key targets for innovative therapeutic strategies. Although BH3-mimetics (i.e. ABT-737) potently inhibit
Autor:
Mor Sény Gueye, Laurent Poulain, Florence Giffard, Monique N'Diaye, Bernard Lambert, Marie-Hélène Louis, Edwige Abeilard, Emilie Brotin, Pascal Gauduchon, Marie-Laure Bonnefond
Publikováno v:
Apoptosis
Ovarian carcinoma is the leading cause of death from gynecologic cancer in the developed world and is characterized by acquired chemoresistance leading to an overall 5-year survival rate of about 30 %. We previously showed that Bcl-xL and Mcl-1 coope
Autor:
Bonnefond, Marie-Laure, Florent, Romane, Lenoir, Sophie, Lambert, Bernard, Abeilard, Edwige, Giffard, Florence, Louis, Marie-Hélène, Elie, Nicolas, Briand, Mélanie, Vivien, Denis, Poulain, Laurent, Gauduchon, Pascal, N'Diaye, Monique
Publikováno v:
Oncotarget
Oncotarget, Impact journals, 2018, 9 (74), pp.33896-33911. ⟨10.18632/oncotarget.26084⟩
Oncotarget, Impact journals, 2018, 9 (74), pp.33896-33911. ⟨10.18632/oncotarget.26084⟩
International audience; The anti-apoptotic proteins Bcl-xL and Mcl-1 have been identified to play a pivotal role in apoptosis resistance in ovarian cancer and constitute key targets for innovative therapeutic strategies. Although BH3-mimetics (i.e. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c541c9a40db0b629cc6eab7c9984ede6
https://www.hal.inserm.fr/inserm-02102500/document
https://www.hal.inserm.fr/inserm-02102500/document